Trial will evaluate DF-006, a first-in-class ALPK1 agonist that stimulates local innate immunity in the liver
Guilford, CT & Shanghai, September 26, 2023
–(BUSINESS WIRE)–Drug Farm, a clinical-stage biopharmaceutical company, today announced that it has studied the first patient with chronic hepatitis B in Part 3 of its Phase 1 clinical trial (ANZCTR Trial ID: ACTRN12621000592842). Medication. The trial is evaluating Drug Farm’s first-in-class ALPK1 agonist DF-006 as monotherapy and in combination with a standard-of-care nuclearPublishers Mindscape Developers P.F. Magic Release date 1998 Genre Simulation Game rating Description of the…
Editors Activision, Inc. Developers superego games Release date 2006 Gender Adventure Game Rating Game Description…
Editors Terraglyph Interactive Studios, Warner Bros. Interactive Entertainment. Developers Terraglifo interactive studios Release date nineteen…
Editors Sega, Digital Images, Screaming Villains, Limited Run Games Developers Digital Images, Inc. Release date…
Editors Davilex Games BV Developers Davilex Games BV Release date 1998 Gender Careers Game Rating…
Editors Sony Computer Entertainment, Disney Interactive Studios Developers High voltage software Release date 2002 Gender…